Načítá se...
Bevacizumab or laser for aggressive posterior retinopathy of prematurity
PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...
Uloženo v:
| Vydáno v: | Taiwan J Ophthalmol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/ https://ncbi.nlm.nih.gov/pubmed/30637196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|